{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:18:08Z","timestamp":1791897488849,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.eprac.2022.10.001","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T04:57:09Z","timestamp":1665550629000},"page":"214-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Automated Insulin Delivery Systems as a Treatment for Type 2 Diabetes Mellitus: A Review"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8277-9932","authenticated-orcid":false,"given":"Alexander B.","family":"Karol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grenye","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshmitha","family":"Fallurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eprac.2022.10.001_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J\u00a0Epidemiol Glob Health"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.001_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-8587(18)30303-6","article-title":"Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis","volume":"7","author":"Basu","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.eprac.2022.10.001_bib4","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.2337\/db11-1445","article-title":"Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia","volume":"61","author":"Breton","year":"2012","journal-title":"Diabetes"},{"issue":"S3","key":"10.1016\/j.eprac.2022.10.001_bib5","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1089\/dia.2017.0035","article-title":"Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes","volume":"19","author":"Rodbard","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2022.10.001_bib6","doi-asserted-by":"crossref","first-page":"k1310","DOI":"10.1136\/bmj.k1310","article-title":"Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis","volume":"361","author":"Bekiari","year":"2018","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.eprac.2022.10.001_bib7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2337\/dc15-2815","article-title":"Randomized summer camp crossover trial in 5- to 9-year-old children: outpatient wearable artificial pancreas is feasible and safe","volume":"39","author":"Del Favero","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.001_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/dom.14187","article-title":"Effect of nutrition on postprandial glucose control in hospitalized patients with type 2 diabetes receiving fully automated closed-loop insulin therapy","volume":"23","author":"Banholzer","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.eprac.2022.10.001_bib9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/dom.13052","article-title":"The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes","volume":"20","author":"Gingras","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1016\/j.eprac.2022.10.001_bib10","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.2337\/dc21-0172","article-title":"Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes","volume":"44","author":"Brown","year":"2021","journal-title":"Diabetes Care"},{"issue":"13","key":"10.1016\/j.eprac.2022.10.001_bib11","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/jama.2016.11708","article-title":"Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes","volume":"316","author":"Bergenstal","year":"2016","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.eprac.2022.10.001_bib12","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/dom.14424","article-title":"Real-world performance of the MiniMed\u2122 670G system in Europe","volume":"23","author":"Da Silva","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.eprac.2022.10.001_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/dia.2020.0388","article-title":"Real-world patient-reported outcomes and glycemic results with initiation of Control-IQ Technology","volume":"23","author":"Pinsker","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"10.1016\/j.eprac.2022.10.001_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/dia.2021.0203","article-title":"Real-world performance of the MiniMed\u2122 780G System: first report of outcomes from 4120 users","volume":"24","author":"Silva","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2022.10.001_bib15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2337\/db22-761-P","article-title":"761-P: long-term glycemic control in adult participants using Control-IQ Technology: real-world evidence","volume":"71","author":"Graham","year":"2022","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.eprac.2022.10.001_bib16","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/s41591-021-01453-z","article-title":"Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial","volume":"27","author":"Boughton","year":"2021","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.eprac.2022.10.001_bib17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/dia.2021.0097","article-title":"One year real-world use of the Control-IQ advanced hybrid closed-loop technology","volume":"23","author":"Breton","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2022.10.001_bib18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2337\/db22-759-P","article-title":"759-P: glycemic outcomes over 15 months with the Omnipod 5 automated insulin delivery system","volume":"71","author":"Criego","year":"2022","journal-title":"Diabetes"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2022.10.001_bib19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2337\/db22-776-P","article-title":"776-P: glycemic outcomes after six months of eal-world MiniMed 780G advanced hybrid closed-loop (AHCL) therapy use in Chile","volume":"71","author":"Castro","year":"2022","journal-title":"Diabetes"},{"issue":"18","key":"10.1016\/j.eprac.2022.10.001_bib20","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","article-title":"Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.eprac.2022.10.001_bib21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2337\/ds18-0091","article-title":"A\u00a0clinical overview of insulin pump therapy for the management of diabetes: past, present, and future of intensive therapy","volume":"32","author":"Berget","year":"2019","journal-title":"Diabetes Spectr"},{"issue":"5","key":"10.1016\/j.eprac.2022.10.001_bib22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1464-5491.2008.02418.x","article-title":"Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in type 2 diabetes","volume":"25","author":"Parkner","year":"2008","journal-title":"Diabet Med"},{"issue":"9","key":"10.1016\/j.eprac.2022.10.001_bib23","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.2337\/diacare.26.9.2598","article-title":"Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study","volume":"26","author":"Raskin","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.001_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1464-5491.2004.01359.x","article-title":"Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life","volume":"22","author":"McMahon","year":"2005","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.eprac.2022.10.001_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1464-5491.2005.01738.x","article-title":"Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial","volume":"23","author":"Hoogma","year":"2006","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.001_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2822","article-title":"The role of insulin pump therapy for type 2 diabetes mellitus","volume":"33","author":"Landau","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"issue":"Supplement 2","key":"10.1016\/j.eprac.2022.10.001_bib27","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.2337\/dcS13-2027","article-title":"Insulin pump for type 2 diabetes: use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes","volume":"36","author":"Reznik","year":"2013","journal-title":"Diabetes Care"},{"issue":"9950","key":"10.1016\/j.eprac.2022.10.001_bib28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(14)61037-0","article-title":"Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial","volume":"384","author":"Reznik","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.001_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4158\/EP12104.OR","article-title":"Use of insulin pump therapy in patients with type 2 diabetes after failure of multiple daily injections","volume":"19","author":"Leinung","year":"2013","journal-title":"Endocr Pract"},{"issue":"11","key":"10.1016\/j.eprac.2022.10.001_bib31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrendo.2014.142","article-title":"Diabetes: insulin pump therapy for type 2 diabetes mellitus","volume":"10","author":"Pickup","year":"2014","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"10.1016\/j.eprac.2022.10.001_bib32","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1464-5491.2011.03256.x","article-title":"Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial","volume":"28","author":"Hermanides","year":"2011","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.001_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1399-5448.2011.00793.x","article-title":"Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study","volume":"13","author":"Slover","year":"2012","journal-title":"Pediatr Diabetes"},{"issue":"12","key":"10.1016\/j.eprac.2022.10.001_bib34","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1089\/dia.2013.0078","article-title":"Hypoglycemia and blood glucose fluctuations in the application of a sensor-augmented insulin pump","volume":"15","author":"Luo","year":"2013","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.eprac.2022.10.001_bib35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.diabet.2016.12.009","article-title":"Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: time to reach target glucose","volume":"43","author":"Gu","year":"2017","journal-title":"Diabetes Metab"},{"issue":"2","key":"10.1016\/j.eprac.2022.10.001_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/pedi.12971","article-title":"Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months","volume":"21","author":"Messer","year":"2020","journal-title":"Pediatric Diabetes"},{"issue":"12","key":"10.1016\/j.eprac.2022.10.001_bib37","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.2337\/dc19-0855","article-title":"One year clinical experience of the first commercial hybrid closed-loop system","volume":"42","author":"Lal","year":"2019","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2022.10.001_bib38","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/dc20-2250","article-title":"Improved glycemic outcomes with Medtronic MiniMed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes","volume":"44","author":"Collyns","year":"2021","journal-title":"Diabetes Care"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2022.10.001_bib39","doi-asserted-by":"crossref","DOI":"10.2337\/db21-102-LB","article-title":"102-LB: six-month glycemic control with a hybrid closed-loop system in type 1 diabetes patients during COVID-19 pandemic in Argentina","volume":"70","author":"Proietti","year":"2021","journal-title":"Diabetes"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2022.10.001_bib40","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2337\/db22-760-P","article-title":"760-P: performance of the MiniMed 780G system with the Guardian 4 sensor\u2014impact on the first 1,570 real-world users","volume":"71","author":"Shin","year":"2022","journal-title":"Diabetes"},{"issue":"10270","key":"10.1016\/j.eprac.2022.10.001_bib57","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(20)32514-9","article-title":"A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial","volume":"397","author":"Bergenstal","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.eprac.2022.10.001_bib41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1056\/NEJMoa1805233","article-title":"Closed-loop insulin delivery for glycemic control in noncritical care","volume":"379","author":"Bally","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.eprac.2022.10.001_bib42","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/dc13-1030","article-title":"Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled study","volume":"37","author":"Kumareswaran","year":"2014","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2022.10.001_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-8587(16)30280-7","article-title":"Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial","volume":"5","author":"Thabit","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2022.10.001_bib58","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.2337\/dc18-2406","article-title":"Efficacy of artificial pancreas use in patients with type 2 diabetes using intensive insulin therapy: a randomized crossover pilot trial","volume":"42","author":"Taleb","year":"2019","journal-title":"Diabetes Care"},{"issue":"S1","key":"10.1016\/j.eprac.2022.10.001_bib47","article-title":"The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes CONFERENCE 27\u201330 April 2022 I BARCELONA & ONLINE","volume":"24","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"10.1016\/j.eprac.2022.10.001_bib45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.kint.2019.03.006","article-title":"Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis","volume":"96","author":"Bally","year":"2019","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.eprac.2022.10.001_bib44","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/dia.2020.0387","article-title":"Robust determination of the optimal continuous glucose monitoring length of intervention to evaluate long-term glycemic control","volume":"23","author":"Herrero","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.eprac.2022.10.001_bib46","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/cc12838","article-title":"Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial","volume":"17","author":"Leelarathna","year":"2013","journal-title":"Critical Care"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2022.10.001_bib48","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2337\/db22-769-P","article-title":"769-P: glycemic outcomes in adults with type 2 diabetes over 21 weeks with the Omnipod 5 automated insulin delivery system","volume":"71","author":"DAVIS","year":"2022","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.eprac.2022.10.001_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001753","article-title":"Long-term variability of glycemic markers and risk of all-cause mortality in type 2 diabetes: the Look AHEAD study","volume":"8","author":"Kaze","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.eprac.2022.10.001_bib52","unstructured":"Shaughnessy AF. Detrimental effect of tight glucose control on CV mortality persists over nine years. Am Fam Physician. 15 2017;95(6):Online."},{"issue":"4","key":"10.1016\/j.eprac.2022.10.001_bib53","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/1932296816633233","article-title":"The potential cost implications of averting severe hypoglycemic events requiring hospitalization in high-risk adults with type 1 diabetes using real-time continuous glucose monitoring","volume":"10","author":"Bronstone","year":"2016","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"2","key":"10.1016\/j.eprac.2022.10.001_bib54","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2337\/cd21-0083","article-title":"Clinical implementation of the Omnipod 5 automated insulin delivery system: key considerations for training and onboarding people with diabetes","volume":"40","author":"Berget","year":"2022","journal-title":"Clin Diabetes"},{"issue":"11","key":"10.1016\/j.eprac.2022.10.001_bib55","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1007\/s10439-016-1679-2","article-title":"A\u00a0review of safety and design requirements of the artificial pancreas","volume":"44","author":"Blauw","year":"2016","journal-title":"Ann Biomed Eng"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.001_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22006322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22006322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:14:18Z","timestamp":1761516858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22006322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1530891X22006322"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.10.001","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automated Insulin Delivery Systems as a Treatment for Type 2 Diabetes Mellitus: A Review","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}